These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 21540351)
1. High-content analysis of CCR2 antagonists on human primary monocytes. Kredel S; Wolff M; Hobbie S; Bieler M; Gierschik P; Heilker R J Biomol Screen; 2011 Aug; 16(7):683-93. PubMed ID: 21540351 [TBL] [Abstract][Full Text] [Related]
2. Assessment of chemokine receptor function on monocytes in whole blood: In vitro and ex vivo evaluations of a CCR2 antagonist. Wisniewski T; Bayne E; Flanagan J; Shao Q; Wnek R; Matheravidathu S; Fischer P; Forrest MJ; Peterson L; Song X; Yang L; Demartino JA; Struthers M J Immunol Methods; 2010 Jan; 352(1-2):101-10. PubMed ID: 19913021 [TBL] [Abstract][Full Text] [Related]
3. Recent developments in CCR2 antagonists. Xia M; Sui Z Expert Opin Ther Pat; 2009 Mar; 19(3):295-303. PubMed ID: 19441905 [TBL] [Abstract][Full Text] [Related]
5. HMG-CoA reductase inhibition reduces monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated monocyte recruitment in vivo. Han KH; Ryu J; Hong KH; Ko J; Pak YK; Kim JB; Park SW; Kim JJ Circulation; 2005 Mar; 111(11):1439-47. PubMed ID: 15781755 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of INCB3344, a small molecule antagonist of human CCR2. Shin N; Baribaud F; Wang K; Yang G; Wynn R; Covington MB; Feldman P; Gallagher KB; Leffet LM; Lo YY; Wang A; Xue CB; Newton RC; Scherle PA Biochem Biophys Res Commun; 2009 Sep; 387(2):251-5. PubMed ID: 19576173 [TBL] [Abstract][Full Text] [Related]